79 related articles for article (PubMed ID: 7590419)
41. A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapy.
Vialettes B; Picq R; du Rostu M; Charbonnel B; Rodier M; Mirouze J; Vexiau P; Passa P; Pehuet M; Elgrably F
Diabet Med; 1990; 7(8):731-5. PubMed ID: 2147636
[TBL] [Abstract][Full Text] [Related]
42. [Long-term remission in fresh acute diabetes mellitus].
Mirouze J; Renard E; Rodier M
Presse Med; 1987 Oct; 16(32):1570-3. PubMed ID: 2958831
[TBL] [Abstract][Full Text] [Related]
43. [Remission of diabetes mellitus].
Tanaka Y; Kashiwagi A; Shigeta Y
Nihon Rinsho; 1991 Feb; 49 Suppl():398-404. PubMed ID: 1827849
[No Abstract] [Full Text] [Related]
44. The honeymoon phase - what we know today about the factors that can modulate the remission period in type 1 diabetes.
Sokołowska M; Chobot A; Jarosz-Chobot P
Pediatr Endocrinol Diabetes Metab; 2016; 22(2):66-70. PubMed ID: 28329775
[TBL] [Abstract][Full Text] [Related]
45. Cyclosporin therapy for prevention and cure of IDDM. Epidemiological perspective of benefits and risks.
Lipton R; LaPorte RE; Becker DJ; Dorman JS; Orchard TJ; Atchison J; Drash AL
Diabetes Care; 1990 Jul; 13(7):776-84. PubMed ID: 2201500
[TBL] [Abstract][Full Text] [Related]
46. Association between physical activity before diagnosis and the presence of clinical remission in type 1 diabetes - InlipoDiab1 study.
Flotyńska J; Jaz K; Cieluch A; Grzelka-Woźniak A; Kaczmarek A; Pypeć A; Ciepłucha W; Nowicka A; Zozulińska-Ziółkiewicz D; Uruska A
Diabetes Metab Res Rev; 2022 Mar; 38(3):e3510. PubMed ID: 34729892
[TBL] [Abstract][Full Text] [Related]
47. The Remission Phase in Type 1 Diabetes: Role of Hyperglycemia Rectification in Immune Modulation.
Tang R; Zhong T; Wu C; Zhou Z; Li X
Front Endocrinol (Lausanne); 2019; 10():824. PubMed ID: 31849842
[TBL] [Abstract][Full Text] [Related]
48. Depleting T cells in newly diagnosed autoimmune (type 1) diabetes--are we getting anywhere?
Lernmark Å
Diabetes; 2013 Nov; 62(11):3669-70. PubMed ID: 24158996
[No Abstract] [Full Text] [Related]
49. Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy.
Schmidt SC; Ann Huey M; Whitley HP
Diabetes Spectr; 2016 Feb; 29(1):50-3. PubMed ID: 26912966
[No Abstract] [Full Text] [Related]
50. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery.
Taylor R; Al-Mrabeh A; Zhyzhneuskaya S; Peters C; Barnes AC; Aribisala BS; Hollingsworth KG; Mathers JC; Sattar N; Lean MEJ
Cell Metab; 2018 Oct; 28(4):667. PubMed ID: 30282047
[No Abstract] [Full Text] [Related]
51. Retraction. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue.
Lee HC; Kim KS; Shin HC
Nature; 2009 Apr; 458(7238):660. PubMed ID: 19340080
[No Abstract] [Full Text] [Related]
52. C-2 monitoring for cyclosporin: considerations for implementation.
Zolezzi M
Saudi J Kidney Dis Transpl; 2004; 15(2):119-24. PubMed ID: 17642761
[No Abstract] [Full Text] [Related]
53. Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia.
Sanchez-Pernaute O; Romero-Bueno FI; Selva-O'Callaghan A
Reumatol Clin; 2021 Nov; 17(9):555-557. PubMed ID: 32354685
[No Abstract] [Full Text] [Related]
54. Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission.
Sachs S; Bastidas-Ponce A; Tritschler S; Bakhti M; Böttcher A; Sánchez-Garrido MA; Tarquis-Medina M; Kleinert M; Fischer K; Jall S; Harger A; Bader E; Roscioni S; Ussar S; Feuchtinger A; Yesildag B; Neelakandhan A; Jensen CB; Cornu M; Yang B; Finan B; DiMarchi RD; Tschöp MH; Theis FJ; Hofmann SM; Müller TD; Lickert H
Nat Metab; 2020 Apr; 2(4):380. PubMed ID: 33820985
[No Abstract] [Full Text] [Related]
55. The Association of Autoimmune Diseases with Type 1 Diabetes Mellitus in Children Depends Also by the Length of Partial Clinical Remission Phase (Honeymoon).
Ozen G; Zanfardino A; Confetto S; Piscopo A; Casaburo F; Tinto N; Iafusco F; Ozen G; Miraglia Del Giudice E; Tasar MA; Yilmaz A; Iafusco D
Int J Endocrinol; 2020; 2020():2630827. PubMed ID: 32215008
[TBL] [Abstract][Full Text] [Related]
56. [Use of cyclosporin A for remission induction in newly-detected insulin-dependent diabetes].
Zamaklar M; Lalić N; Djordjević P; Dragasević M; Vujosević S; Savić K; Kalimanovska V
Glas Srp Akad Nauka Med; 1994; (44):89-100. PubMed ID: 7590419
[TBL] [Abstract][Full Text] [Related]
57. [Remission of diabetes during conventional insulin therapy or therapy controlled by use of an artificial pancreas].
Mirouze J; Selam JL; Pham TC; Mendoza E
Sem Hop; 1979 Feb 18-25; 55(7-8):354-9. PubMed ID: 220725
[TBL] [Abstract][Full Text] [Related]
58. Effect of cyclosporine on insulin binding to erythrocytes in type 1 diabetes mellitus of recent onset.
Behme MT; Dupre J; Stiller CR
Clin Invest Med; 1988 Apr; 11(2):113-22. PubMed ID: 3293865
[TBL] [Abstract][Full Text] [Related]
59. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
[TBL] [Abstract][Full Text] [Related]
60. Factors predicting remission in type I diabetes.
Pelkonen R; Aro A
Ann Clin Res; 1984; 16(2):94-7. PubMed ID: 6380392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
